Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's hepatitis C and cirrhosis with decompensated liver function have been granted initial ratings of 40 percent each, effective January 29, 2008. A separate rating for malignant hepatocellular carcinoma has also been granted.

The deciding factor: The evidence shows that the Veteran's hepatitis C symptoms since January 29, 2008 have included daily fatigue, malaise and anorexia with substantial weight loss and hepatomegaly, meeting the criteria for a 40 percent rating under DC 7354.

Claimed conditions
Hepatitis C, Malignant hepatocellular carcinoma (secondary to hepatitis C)
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
40%
Decision date
March 29, 2016
Citation
1612628

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1612628.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.